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ABSTRACT
Objective: This study aimed to evaluate the antihypertensive utilization and drug therapy problems (DTPs) in the treatment of patients with 
hypertension.
Methods: This prospective analytical study used a self-determined questionnaire to collect 2-month period data of hypertensive patients (n=107) 
admitted to four primary health centers in Medan (Medan Deli, Helvetia, Glugur Darat, and Teladan). Inclusion criteria were patients diagnosed 
with hypertension, age ≥18 years, and under treatment of antihypertensive drugs. Data collected include gender, age, education, the administered 
antihypertensive drugs, and DTPs. Characteristics of the patients were descriptively analyzed. DTPs were identified based on strand classification 
system and trustable literature. All analyzes were performed using Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) 
(p<0.05 was considered significant).
Results: Characteristics of the patients: Male, 25.2%; female, 74.8%; mean age, 61.6±10.3 (years). Education: Primary school, 25.2%; junior high 
school, 17.8%; senior high school, 43.9%; university, 13.1%. The most frequently provided antihypertensive drugs were amlodipine (47.7%) and 
captopril (22.4%). Overall, there were 66 DTPs experienced by 45.8% of the patients. Patients experienced: 1 DTP, 75.5%; 2 DTPs, 18.3%; 3 DTPs, 
2.1%; 4 DTPs, 4.1%. There was no significant association between the patients’ education and DTPs, p=0.88. The most frequently occurred DTP (47%) 
was indication without drug therapy in which patients with hypertension Stage 2 only received single antihypertensive drugs mostly was captopril.
Conclusion: The most frequently provided antihypertensive drug was captopril. DTPs in the management of hypertensive patients are still high in 
primary health centers in Medan and need to be resolved.
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INTRODUCTION
Hypertension remains a worldwide public health threat, especially in 
lower-middle income countries including South-East Asia. It is the silent 
contributor to stroke, cardiovascular diseases, and kidney disorders 
that ultimately cause inability and even death. Inadequate control 
and treatment of hypertension are strongly associated with risks for 
developing stroke and increasing mortality [1,2]. A study indicated that 
about 35% of adults in South-East Asia have blood pressure (BP) above 
normal and result in death as many as 1.5 million people per year. It 
has been proved that the prevalence of hypertension is high in almost 
all South-East Asian countries of which the highest one was located in 
Indonesia which reached 41.1% [3].
Treatments of hypertension without referring to established clinical 
practice guidelines can result in drug therapy problems (DTPs), failure 
to achieve targeted BP, various complications as previously mentioned, 
and high consumption of health care costs. DTPs are generally defined as 
events or circumstances involving drug therapy that actually or potentially 
interfere with desired health outcomes [4]. DTPs have been classified by 
different groups with different ways of classification in various countries; 
four of the most widely applied classifications are Strand (in the US), 
Apoteket (in Sweden), Granada-II (in Spain), and Pharmaceutical Care 
Network Europe (PCNE) (in Europe) classification systems. Nevertheless, 
these classification systems deal with drug choice, drug dosage, drug 
interaction, adverse drug reactions, and adherence problems.
Few studies on DTPs applying different classification methods have been 
undertaken and associated with patients’ outcomes, as well as healthcare 
costs. A study performed in Jepara, Indonesia in 2007 indicated that 
64 (77.11%) of 83 hypertensive patients with Type 2 diabetes mellitus 
experienced DTPs of which unsafe drug choice contributed 49.19% of 
the overall incidence [5]. Subsequently, a pooled analysis proved that 
incorrect drug doses reached 20.4% of the overall DTPs occurrence [6]. 
Ernst and Grizzle [7] found that every US $1 spent for medication 
required US $1.77 to resolve DTPs. Up to now, there have been limited 
studies conducted locally to identify, analyze, and document DTPs in the 
management of patients with hypertension. Therefore, DTPs become 
critical issues and challenge to healthcare providers.
Kidney Disease Quality Outcomes Initiatives Clinical practice guidelines 
in Guidelines 2 and 13 state that strategies are emphasized on 
identification and prevention. These statements imply that risk factors 
for kidney disease, one of which is hypertension, should be identified 
and managed properly to prevent further progression of kidney 
damage. Thus, medication reviews, evaluation, and resolving DTPs in 
the management of hypertension are the main points required to be 
implemented to improve treatment outcomes and to reduce costs. 
Subsequently, recommendations to resolve the DTPs, based on the 
findings, should be informed by pharmacists to health care providers as 
well as patients to improve health services [8,9].
In relation to the above problems, the present study focused on 
antihypertensive utilization, identification, and analysis of DTPs in 
the management of hypertensive patients as well as the association 
between the patients’ education and occurrence of DTPs in four primary 
health centers in Medan.
METHODS
This study was initiated with a preliminary survey undertaken by the 
researchers to obtain the frequency of hypertensive patients’ admission 
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to primary health centers located in Medan, North Sumatera. It was 
found that four of the health centers with the highest admission of 
hypertensive patients were Medan Deli, Helvetia, Glugur Darat, and 
Teladan. Therefore, these health centers were selected as locations of 
the study. The study was approved by the Department of Health North 
Sumatera and Health Research Ethical Committee of North Sumatera, 
School of Medicine, University of Sumatera Utara, Indonesia. Patients 
diagnosed with hypertension, age ≥18 years, and under treatment of 
antihypertensive drugs were included in this study. This prospective 
analytical study was undertaken by distribution a self-determined 
questionnaire to hypertensive patients (n=107) for a 2-month period 
in the four primary health centers. Data collected to obtain the 
characteristics of the patients were gender, age, and education of the 
patients. The administered antihypertensive drugs and DTPs were 
assessed. Characteristics of the patients were descriptively analyzed. 
DTPs, but limited only to antihypertensive drugs provided to the 
patients, were identified and analyzed based on Strand classification 
system (including medical condition without receiving drug therapy, 
receiving drug therapy without indication, too low doses, too high doses, 
ineffective provided drug, adverse drug reaction, non-compliance/
non-adherence) [10] by referring to trustable literatures [11,12] 
and guidelines for the management of hypertension provided by The 
Seventh Report of the Joint National Committee (JNC 7) on prevention, 
detection, evaluation, and treatment of high BP [13]. All analyzes were 
performed using Statistical Package for the Social Sciences (SPSS, 
version 19, Chicago, IL, USA) (p<0.05 was considered significant).
RESULTS
During the study period, 132 admissions of patients with hypertension 
were found of which 107 patients fulfilled the inclusion criteria. 
Characteristics of the patients by gender are shown in Fig. 1. It was 
obtained that female had higher admission (74.8%) compared to those 
of male (25.2%). Mean age of the hypertensive patients was 61.6±10.3 
(years). 57 of the hypertensive patients were in Stage 1, and 50 patients 
were in Stage 2. According to education, characteristics of the patients 
are demonstrated in Fig. 2. As shown in Fig. 2, about a quarter of them 
(25.2%) graduated from primary schools. Less than one fifth of them 
(17.8%) have junior high school education. Most of the hypertensive 
patients (43.9%) graduated from senior high schools. Only 14 (13.1%) 
of them graduated from universities.
Listed in Table 1 are the antihypertensive drugs in decreasing order 
provided to the patients with hypertension. As shown in Table 1, the 
most frequently provided antihypertensive drug was amlodipine (47.7%) 
followed by captopril (22.4%), and their combination (16.8%). Combination 
therapy of hydrochlorothiazide and amlodipine was only provided to 5.6% 
of the hypertensive patients. As also listed in Table 1, combination therapy 
of HCT and amlodipine was only provided to 2.8% of the patients. Each of 
the rest antihypertensive combinations was only provided to one patient. 
The utilization pattern of the antihypertensive drugs in the treatment 
of the hypertensive patients is mostly affected by the disease severity as 
recommended by the National Formulary as well as JNC 7.
With regards to DTPs, overall, there were 66 DTPs experienced by 
49 (45.8%) of the hypertensive patients as shown in Table 2. The 
66 DTPs experienced by the 49 hypertensive patients vary from 1 
to 4 occurrences. 37 (75.5%) of the 49 patients experienced one 
DTP. 9 (18.3%) of the 49 patients experienced 2 DTPs. 1 (2.1%) 
of the 49 patients experienced 3 DTPs. 2 (4.1%) of the 49 patients 
experienced 4 DTPs. There was no significant association between the 
patient’s education and the number of DTPs occurrences, p=0.88. In 
details, the categories of the DTPs in decreasing order experienced by 
the hypertensive patients are listed in Table 2.
Among the 66 DTPs identified, the most frequently occurred DTP (47%) 
felt into the first category (indication without drug therapy). In this case, 
each of these patients with hypertension Stage 2 only received single 
antihypertensive drugs mostly was captopril. Ineffective outcome (no 
BP reduction) was observed in 21.2% of the overall DTPs, even though 
the patients were on Stage 2 and provided captopril and amlodipine 
combination. In addition, non-adherence of the hypertensive patients 
to the prescribed medications was also observed in 13.6% of the DTPs 
occurred. Subsequently, adverse drug reaction (cough) was noticed in 
9.1% of the DTPs occurred. In addition, drug therapy without indication 
was detected in 7.6% of the DTPs experienced by the patients. Too low 
dose of captopril was only noticed in 1.5% of the DTPs. None of the 
hypertensive patients experienced problems with too high dose and 
drug interaction.
DISCUSSIONS
By gender, it was obtained that female had higher admission (74.8%) 
compared to those of male (25.2%). This finding supports previous 
















Fig. 1: Characteristics of the hypertensive patients by gender 
(n=107)
Fig. 2: Characteristics of the hypertensive patients by education 
(n=107)
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studies on hypertensive patients undertaken in Malaysia, USA, and 
Ghana [14-16]. The present study revealed that mean age of the 
hypertensive patients was 61.6±10.3 years. Mean age of hypertensive 
patients varies from one patient group to another. A retrospective study 
conducted on hypertensive patients but with the complication of Type 2 
diabetes in a tertiary hospital revealed that the mean age of the patients 
was 62.3±12.7 years [17]. Other study proved that the mean age of 
hypertensive patients was 62.2±9.7 years [18]. Also, another study 
on hypertensive patients with coronary heart disease conducted at a 
tertiary care teaching hospital in Chidambaram, South India found that 
the mean age of the hypertensive patients was 58.78±12.53 years [19].
The utilization pattern of antihypertensive drugs varies of which 
amlodipine (47.7%), captopril (22.4%), and their combination (16.8%) 
were the most frequently provided antihypertensive drugs to the 
hypertensive patients. Few studies on utilization of antihypertensive 
drugs in patients with hypertension have been undertaken elsewhere. 
A prospective, randomized, controlled study undertaken in a private 
hospital located in Tamil Nadu found that the most widely provided 
antihypertensive drug to patients with hypertension was captopril 
(80.2%) [18]. A similar study conducted in a tertiary care teaching 
hospital Chidambaram, South India found that calcium channel blocker 
(amlodipine), beta blocker (atenolol or metoprolol or carvedilol), and 
angiotensin receptor blocker (telmisartan) were the most frequently 
prescribed drugs in hypertensive patients [19].
The present study proved that 49 (45.8%) of the hypertensive patients 
experienced 66 DTPs felt into seven categories of DTPs in which three 
of the most frequently occurred in decreasing order were indication 
without drug therapy, provision of ineffective antihypertensive drugs, 
and non-adherence of the hypertensive patients to the treatment. 47% 
of the overall DTPs were indication without drug therapy in which the 
patients were on Hypertension Stage 2, but they were only provided 
single antihypertensive drugs, mostly was captopril. According to 
clinical practice guidelines, these patients should be provided at least 
two antihypertensive combinations [13]. Failure to reduce BP was the 
second highest incidence (21.2%) of DTPs found in the present study, 
even though a combination of antihypertensive drugs (captopril and 
amlodipine) have been provided to the hypertensive patients with 
Stage 2. In this condition, other classes of antihypertensive drugs 
may be required to improve the patients’ outcome [20]. However, 
due to resources limitation available in these health centers, these 
antihypertensive classes were not provided to these patients. 
In addition, non-adherence of the hypertensive patients to the 
prescribed medications contributed to 13.6% of the DTPs occurred. 
In this case, the patients stopped taking antihypertensive drugs 
because they either felt that they were cured or missed doses due to 
irregular visits to physicians. Few studies proved that provision of 
counseling to hypertensive patients improved their adherence to their 
medications [21-23]. Adverse drug reaction (cough) contributed to 9.1% 
of the overall DTPs occurred. This adverse drug reaction was noticed in 
patients provided captopril therapy. Other classes of antihypertensive 
drugs should be provided if the patients were not complied with the 
treatment. In addition, drug therapy without indication (drug overuse) 
was detected in 7.6% of the DTPs experienced by the patients. In this 
case, patients with Stage 1 received combination therapy. Risk for 
sudden hypotension may occur in a certain patient group such as older 
persons. Thus, caution is required. Single antihypertensive drug should 
have been initially provided to these patients. When the provision of 
a single drug therapy is inadequate to lower BP, combination therapy 
should be provided instead. Too low dose of captopril was only noticed 
in 1.5% of the DTPs. Frequently BP monitoring should be practiced to 
consider if dose adjustment is required [13].
This study was limited by the relatively a short time horizon that may 
have impacts on the results of the study.
CONCLUSIONS
Various classes of antihypertensive drugs were provided to the 
patients with hypertension. The three most frequently provided 
antihypertensive drugs were amlodipine (47.7%), captopril (22.4%), 
and their combination (16.8%). Nearly half of the patients experienced 
DTPs. The most frequently occurred DTP (47%) felt into the first 
category (indication without drug therapy) in which patients with 
hypertension Stage 2 only received single antihypertensive drugs. 
DTPs occurrence in the management of patients with hypertension in 
primary health centers in Medan was still high and need to be resolved.
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